Mark your calendars for a transformative experience! The 13th Day of Learning, hosted by the Autism Science Foundation, is set to take place on March 26, 2026, in the heart of New York City at 583 Park Ave. This in-person event promises to be a beacon of knowledge, bringing together leading minds in autism research to explore groundbreaking discoveries and controversial topics. But here's where it gets exciting: the lineup of speakers is nothing short of extraordinary, each addressing critical aspects of autism science that are reshaping our understanding of the field.
Featured Talks for the 13th Day of Learning:
- Josh Gordon (Columbia and NIH) will delve into Understanding the Changing Autism Research Landscape, offering insights into how the field is evolving and what it means for the future.
- Helen Tager-Flusberg (Coalition for Autism Scientists, Boston University) presents Pushing Back: Autism Scientists Speak Out, a bold discussion on the challenges and triumphs within the scientific community.
- David Mandell (University of Pennsylvania) explores The Promise of the Federal ADSI Studies, shedding light on the potential breakthroughs from these large-scale initiatives.
- John Spiro (Simons Foundation) discusses Confirming New Autism Subtypes, a topic that could revolutionize personalized treatments.
- Stephan Sanders (Oxford University and UCSF) examines Prospects for Genetic Medicines, a cutting-edge look at how genetics might hold the key to future therapies.
- Diana Schendel (Drexel University) investigates Understanding Family Recurrence Beyond the First Degree, uncovering the broader familial implications of autism.
And this is the part most people miss: Last year's 12th Day of Learning was equally groundbreaking, featuring talks that tackled some of the most innovative and debated topics in autism research. Here’s a glimpse into what was covered:
- Dr. Allyson Berent (Angelman Syndrome Therapeutics) discussed Gene Editing and Gene Therapies in Genetically-Defined Autisms, a frontier that raises both hope and ethical questions.
- Dr. Robert Schultz (University of Pennsylvania) explored Leveraging AI Tools to Characterize Autism, highlighting the role of technology in advancing our understanding.
- Dr. David Amaral (University of California, Davis) emphasized The Critical Role of Families in Autism Research Utilizing Post-Mortem Brain Tissue, a sensitive yet vital area of study.
- Dr. Rebeca Levy (Stanford University) introduced Organoids and Assembloids for Personalized Profound Autism Treatment, a futuristic approach to tailored therapies.
- Dr. Elena Tenenbaum (Duke University) presented Utilizing AI to Understand Early Development in Infants, offering a window into the earliest stages of life.
- Dr. Heather Nuske (University of Pennsylvania) shared insights on Using Wearable Devices to Reduce Severe Behaviors in Students with Profound Autism, a practical application of technology with real-world impact.
Controversy Alert: While these advancements are undeniably exciting, they also spark debate. For instance, the use of AI and genetic editing in autism research raises questions about ethics, accessibility, and the potential for unintended consequences. What do you think? Are these technologies a step forward or a slippery slope? We’d love to hear your thoughts in the comments below. Join us on March 26, 2026, to be part of this vital conversation and explore the future of autism science together!
